Search

Dr Heng was invited by NCI Center to Reduce Cancer Health Disparities (CRCHD) to share her story about the moment that inspired her to work in transgender cancer research. https://twitter.com/NCICRCHD/status/1665818273626353666?s=20

NCI Division of Cancer Biology (DCB) highlighted Dr. Heng's DCB-supported breast cancer research on Twitter/X for Breast Cancer Awareness in October. https://x.com/NCICancerBio/status/1717988909551071461?s=20

Leveraging an artificial intelligence algorithm created by Dr. Heng's team to analyze breast tissue composition—the relative amounts of breast epithelium, fibrous stroma, and fat—the findings suggest that gender-affirming testosterone therapy may decrease the breast cancer risk for trans masculine...

Dr. Heng has been selected to participate in the 2025 SGM Cancer Curriculum Advances Research Excellence (CARE) Workshop in Denver, CO. She will also present relevant basic cancer research that she is leading at the workshop.

Dr. Heng will be presenting, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer." at the 2025 Harvard Institute for RNA Medicine (HiRM) seminar series on Tuesday, February 18th at 3 pm.

Dr. Heng will be a keynote speaker at AI Club's annual Research Symposium. https://corp.aiclub.world/2025-student-research-symposium